Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.0K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.0K
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

504
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
504
External and Internal Respiration01:24

External and Internal Respiration

7.0K
External respiration occurs in the lungs, and it is the first step in the journey of oxygen inside the body. When we inhale, oxygen enters our lungs and diffuses across the thin alveolar membrane. The alveoli are tiny, air-filled sacs that provide a vast surface area for gas exchange. Oxygen in the alveoli has a higher partial pressure (105 mmHg) than in the adjacent pulmonary capillaries (40 mmHg), establishing a pressure gradient. As a result, oxygen molecules move from the alveoli into the...
7.0K
Pneumothorax-I01:26

Pneumothorax-I

1.2K
A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
1.2K
Breathing01:05

Breathing

64.1K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
64.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

2.6K
The pathophysiology of pneumonia involves the following steps:
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Implementing Project Optimus in Oncology Dosage Optimization: Where are We Now?

Therapeutic innovation & regulatory science·2026
Same author

More Than Service: Exploring the Psychological Benefits of Volunteering in 4-H Youth Development Programs.

Journal of community psychology·2026
Same author

Early stroke specialist vocational rehabilitation for REturn To work After stroKE: a synopsis from the RETAKE RCT.

Health technology assessment (Winchester, England)·2026
Same author

A common symptom geometry of mood improvement under sertraline and placebo associated with distinct neural patterns - CORRIGENDUM.

Psychological medicine·2026
Same author

ABO-Incompatible Platelet Transfusions and Mortality Risk in Patients With Intracranial Hemorrhage.

Neurosurgery·2026
Same author

Evaluation of an Opioid Use Disorder Consult Service on Success of Non-Home Discharge Recommendations.

Substance use & addiction journal·2026
Same journal

Monographic Issue on New Concepts in Acute Exacerbations of COPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Bidirectional Clinical Interactions among Exacerbations and Comorbidities in COPD: A Narrative Review.

Seminars in respiratory and critical care medicine·2026
Same journal

Radiological Approach to Severe Respiratory Infections and Pulmonary Complications in Immunocompromised Patients.

Seminars in respiratory and critical care medicine·2026
Same journal

Two Sides of the Same Smoke: Decoding Respiratory Bronchiolitis-Associated Interstitial Lung Disease and Alveolar Macrophage Pneumonia.

Seminars in respiratory and critical care medicine·2026
Same journal

Role of Vaccination in the Prevention of ECOPD.

Seminars in respiratory and critical care medicine·2026
Same journal

Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives.

Seminars in respiratory and critical care medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
07:10

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung

Published on: May 20, 2019

14.4K

Diffuse Alveolar Hemorrhage.

John Murray1, Shane O'Brien1,2, Patrick Mitchell1,2

  • 1Department of Respiratory Medicine, Tallaght University Hospital, Dublin, Ireland.

Seminars in Respiratory and Critical Care Medicine
|October 23, 2025
PubMed
Summary
This summary is machine-generated.

Diffuse alveolar hemorrhage (DAH) is a serious lung condition with diverse causes and often presents without coughing up blood. Early diagnosis and multidisciplinary management are crucial for improving survival rates.

More Related Videos

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

536
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.1K

Related Experiment Videos

Last Updated: Jan 14, 2026

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung
07:10

Direct Intrabronchial Administration to Improve the Selective Agent Deposition Within the Mouse Lung

Published on: May 20, 2019

14.4K
Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

536
Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
09:36

Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device

Published on: September 24, 2020

3.1K

Area of Science:

  • Pulmonary Medicine
  • Critical Care Medicine
  • Pathology

Background:

  • Diffuse alveolar hemorrhage (DAH) is a life-threatening syndrome of pulmonary microcirculation bleeding into alveoli.
  • It presents with acute respiratory failure, anemia, and infiltrates, but hemoptysis is absent in up to 50% of cases.
  • Diverse etiologies include vasculitis, connective tissue diseases, coagulopathies, infections, and drug-induced processes.

Purpose of the Study:

  • To review the histopathological spectrum, etiologic categories, diagnostic algorithms, and therapeutic approaches for DAH.
  • To emphasize the importance of early multidisciplinary management for improving survival and functional recovery.

Main Methods:

  • Histopathological classification into pulmonary capillaritis, bland alveolar hemorrhage, or diffuse alveolar damage.
  • Diagnostic evaluation combining imaging, bronchoalveolar lavage, and targeted laboratory tests.
  • Review of evidence-based therapeutic strategies including immunosuppression, plasma exchange, and supportive care.

Main Results:

  • Histopathology guides diagnosis and treatment: capillaritis often requires immunosuppression, bland hemorrhage suggests coagulopathy, and diffuse alveolar damage links to toxins or ARDS.
  • Prompt recognition and systematic evaluation are critical due to DAH's high in-hospital mortality (>20%).
  • Management involves stabilization, etiology-directed therapy (e.g., corticosteroids, rituximab, plasma exchange), and supportive measures.

Conclusions:

  • DAH necessitates a systematic approach integrating histopathology, etiology, and timely intervention.
  • Multidisciplinary management is paramount for optimizing outcomes in this critical condition.
  • Early diagnosis and tailored therapy significantly improve survival and functional recovery in patients with DAH.